Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Easterbrook

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
European Journal of Immunology|December 18, 2001
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infectionA Oxenius, S Fidler, M Brady, et al.
Personality & Social Psychology Bulletin|March 12, 2024
Populism, Economic Distress, Cultural Backlash, and Identity Threat: Integrating Patterns and Testing Cross-National ValidityEfisio Manunta, Maja Becker, Vivian L Vignoles, et al.
European Journal of Immunology|April 12, 2001
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus loadA Oxenius, H F Günthard, B Hirschel, et al.
AIDS (London, England)|May 23, 2014
Community and service provider views to inform the 2013 WHO consolidated antiretroviral guidelines: key findings and lessons learntAmy C Hsieh, Gitau Mburu, Adam B J Garner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2000
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytesA Oxenius, D A Price, P J Easterbrook, et al.
AIDS (London, England)|June 5, 2002
Complete mapping of a novel HLA A*6801-restricted HIV-1 Tat epitope directly with a rapid modified enzyme-linked immunospot assayAnnette Oxenius, Bent K Jakobsen, Philippa J Easterbrook, et al.
Annals of Internal Medicine|June 21, 2016
Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysisJ Morgan Freiman, Trang M Tran, Samuel G Schumacher, et al.
Vaccine|June 17, 1998
Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestisK M Reddin, T J Easterbrook, S M Eley, et al.
Antiviral Therapy|October 2, 2003
Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patientsCaroline A Sabin, Ed Wilkins, Maurice Murphy, et al.
AIDS (London, England)|January 29, 2014
Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South AfricaNatasha K Martin, Angela Devine, Jeffrey W Eaton, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Immunology|December 18, 2001
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infectionA Oxenius, S Fidler, M Brady, et al.
Personality & Social Psychology Bulletin|March 12, 2024
Populism, Economic Distress, Cultural Backlash, and Identity Threat: Integrating Patterns and Testing Cross-National ValidityEfisio Manunta, Maja Becker, Vivian L Vignoles, et al.
European Journal of Immunology|April 12, 2001
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus loadA Oxenius, H F Günthard, B Hirschel, et al.
AIDS (London, England)|May 23, 2014
Community and service provider views to inform the 2013 WHO consolidated antiretroviral guidelines: key findings and lessons learntAmy C Hsieh, Gitau Mburu, Adam B J Garner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2000
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytesA Oxenius, D A Price, P J Easterbrook, et al.
AIDS (London, England)|June 5, 2002
Complete mapping of a novel HLA A*6801-restricted HIV-1 Tat epitope directly with a rapid modified enzyme-linked immunospot assayAnnette Oxenius, Bent K Jakobsen, Philippa J Easterbrook, et al.
Annals of Internal Medicine|June 21, 2016
Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysisJ Morgan Freiman, Trang M Tran, Samuel G Schumacher, et al.
Vaccine|June 17, 1998
Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestisK M Reddin, T J Easterbrook, S M Eley, et al.
Antiviral Therapy|October 2, 2003
Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patientsCaroline A Sabin, Ed Wilkins, Maurice Murphy, et al.
AIDS (London, England)|January 29, 2014
Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South AfricaNatasha K Martin, Angela Devine, Jeffrey W Eaton, et al.
Pageof 17